Upload
tga-australia
View
323
Download
1
Embed Size (px)
DESCRIPTION
This presentation provided an overview on manufacturing medical devices and the regulatory considerations
Citation preview
Manufacturing medical devicesRegulatory considerations
Dr Ying Huang Inspector, Office of Manufacturing Quality (OMQ) Monitoring and Compliance Group, TGA !ABEC - Canberra
21 August 2014 1
ABEC - Canberra
Topics➢Role of the Office of Manufacturing Quality (OMQ) ➢Basic requirements for a manufacturer ➢Risk-based program of manufacturer assessment
– Regulate risks relating to product – Regulate risks relating to compliance
➢Conclusion
2
Role of OMQ
3
Australian and overseas
manufacturers are assessed prior to
supply of goods and are then regularly
reviewed
Inspections against conformity assessment
procedures (ISO 13485) and other standards (e.g.
sterilisation standards)
Quality manufacturing
On-site inspections of manufacturers and compliance
verifications (desktop
assessments)
ABEC - Canberra
Basic requirements for a manufacturer➢Manufacturer applies a relevant conformity assessment procedure (CAP)
to demonstrate: • Compliance with Essential Principles (EPs); and
• Implementation of an effective Quality Management System (QMS)
➢Essential Principles • 14 principles for performance and safety, including:
• General risk management;
• Clinical evidence;
• Others
4
ABEC - Canberra
Risk-based program of manufacturer assessment
5
The TGA regulatory framework:
The risks involved with therapeutic goods can be divided into: 1. Risks relating to the product. 2. Risks relating to compliance. Compliance risks relate to the risks involved if a manufacturer or sponsor fails to comply with legal requirements (either unintentionally or intentionally)
ABEC - Canberra
Risk-based program of manufacturer assessment
6
Different types of QMS:
ATG
by
ten
asse
ssm
of
el
le
vTh
e
Part 1 Full Quality Assurance
Part 4 Production Quality Assurance
Part 5 Product Quality Assurance
ceide
vhe
t
for
sks
ri of
el
le
vTh
e
ABEC - Canberra
Regulate risks relating to product
7
Part 1–Full Quality Assurance for manufacturing including design and development
Documents to define the QMS and records to show the system has been applied (clause 4)
Management controls (clause 5)
Resource (human, infrastructure and work environment) management (clause 6)
Design & development control (subclause 7.3)
Purchase: outsourced processes and suppliers (subclause 7.4)
Production and service provision (subclause 7.5)
Measurement, analysis and improvement processes (clause 8)
Risk
man
agem
ent
appl
ying
thr
ough
out
prod
uct
real
isat
ion
ABEC - Canberra
Regulate risks relating to compliance Independent and periodic inspection of a manufacturer:
• By OMQ : ▪ Specifically for combination
products: • Medicines • Animal origin • Microbial substance • Blood components
▪ Types of Inspections • Full • Partial / Surveillance • Unannounced
8
And / Or • By recognised third parties: ▪ EU Notified
Bodies; and ▪ CMDCAS
Registrars (for Health Canada)
ABEC - Canberra
Regulate risks relating to compliance
9
Desktop assessment➢An alternate way to assess the quality of manufacturing of medical devices ➢The assessment criteria are the same as the on-site inspection. ➢Further on-site inspection may be recommended pending on the desktop
assessment outcome. ➢Benefit:
• Reduce regulatory burden; and • Efficiently utilise resources.
ABEC - Canberra
Regulate risks relating to compliance
➢Monitor post-market adverse events – Regulatory requirements—notification (subclause 8.5.1 of ISO 13485) ▪ Adverse-event reporting & recalls; and ▪ Significant changes in device or QMS
➢Undertake a program of laboratory compliance testing
10
To complement the inspection program, other areas of TGA:
ABEC - Canberra 11
Conclusion
1. The TGA manages the risks associated with medical devices by regulating: • Risks relating to product through product assessment and inspection of
manufacturers; and • Risks relating to compliance through post-market compliance activities
including unannounced inspections for problem/complaint investigations. 2. The Office of Manufacturing Quality (OMQ) contributes to TGA’s objectives
through the implementation of the inspection program. 3. ISO 13485 QMS standard has been specified by the conformity
assessment standards order as a tool to assess the manufacturer's QMS.
Thank you for your attention.